Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Seizures 1Neoplasms 1Neoplasm Metastasis 1Lung Neoplasms 1Intestinal Obstruction 1Intestinal Fistula 1Fibrosis 1Brain Neoplasms 1Abdominal Neoplasms 1

Interventions

ziprasidone 1Zolpidem 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Tranexamic Acid 1Tobramycin 1Spironolactone 1Solutions 1Sevelamer 1Rocuronium 1Remifentanil 1Propofol 1Piperacillin, Tazobactam Drug Combination 1Pentobarbital 1Oxycodone 1Nifedipine 1Nafcillin 1Molindone 1Methylprednisolone 1Mental Status and Dementia Tests 1Magnetic Resonance Spectroscopy 1Lurasidone Hydrochloride 1Lenalidomide 1Labetalol 1Haloperidol 1Fosfomycin 1Dexmedetomidine 1Clozapine 1Ciprofloxacin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Seizures × Propofol × Clear all
NCT05103735 2023-01-31

Propofol-remifentanyl Versus Dexmedetomidine in Awake Craniotomy: Impact on Electroclinical Seizure Activity

Azienda Sanitaria-Universitaria Integrata di Udine

Completed
170 enrolled

Seizures

Data powered by HemOnc (CC BY 4.0) Colophon âš¡